Accelerate PD-1/PD-L1 Inhibitor Discovery
we offer an in vitro assay that can quickly, easily, and accurately detect potential drug candidates. Our assay helps you to identify candidate compounds, including antibodies, VHHs (Nanobody), and other peptides, that effectively bind to the target molecule. We help you to optimize your drug development process, reducing both time and cost while delivering a superior final product.
Accelerate (VHH) Nanobody Discovery and Selection
Our in vitro platform has been developed to expedite the selection of novel binders with high specificity and strong affinity for a target molecule of interest. This platform offers a rapid and efficient solution for researchers and pharmaceutical companies, facilitating the discovery of potential drug candidates with precise binding characteristics.
Our protocols are user-friendly and can be adapted to diverse research questions, making them easily implementable in a wide range of experiments. Target molecule are detected in a three-step process. The technology requires minimal preparation and provides results in hours instead of days compared to other identification methods.